Pharmaceutical News

2:27 PM EST
2/8/2012
FDA warns acid reducers can cause severe diarrheaThe Food and Drug Administration warned Wednesday that people who use stomach acid drugs known as proton pump inhibitors may increase their risk of coming down with a type of diarrhea that does not improve. Proton pump inhibitors (PPIs) include such popular brands as Nexium, Prilosec and Prevacid.

Source:AHN Topics:Economy, Business And Finance, Chemicals, Pharmaceutical, Health, Illness, Politics, Regulatory Policy And Organization

11:48 AM EST
1/31/2012
FDA approves new skin cancer drugThe Food and Drug Administration approved medication on Monday that treats the most common type of skin cancer, basal cell carcinoma. Erivedge is intended to treat locally advanced cancer for patients who are not candidates for surgery or radiation, and for patients whose cancer has spread to other parts of the body.

Source:AHN Topics:Economy, Business And Finance, Company Information, New Product, Chemicals, Pharmaceutical, Politics, Regulatory Policy And Organization

11:02 AM EST
1/31/2012
Statins work well for both men and womenA large study shows that statins, used to lower cholesterol, are just as effective for women as men.

Source:AHN Topics:Health, Medical Conditions, Economy, Business And Finance, Chemicals, Pharmaceutical

3:10 PM EST
1/13/2012
Novartis to cut nearly 2,000 U.S. jobsSwiss drugmaker Novartis says it will cut nearly 2,000 jobs in the United States in anticipation of loss of revenue as its patent protection expires on its blockbuster drug Diovan. It is the company's top products and brought in more than $6 billion in revenue in 2010, the most recent year for sales data.

Source:AHN Topics:Economy, Business And Finance, Company Information, Layoffs And Downsizing, Chemicals, Pharmaceutical, Labor, Employment, Job Layoffs

1:28 PM EST
1/11/2012
Lipitor keeps 37 percent of market share against generic rivalsPfizer's cholesterol drug Lipitor is holding onto roughly 37 percent of the overall U.S. market as it competes with generic versions, the company reported Tuesday.

Source:AHN Topics:Economy, Business And Finance, Company Information, Corporate Performance, Health, Medicine, Western, Chemicals, Pharmaceutical

Advertisement
 

6:49 AM EST
1/9/2012
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall Of Certain Over-The-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or GelcapsNovartis Consumer Health Inc. Lincoln, NE facility has voluntarily suspended operations and shipments to accelerate maintenance and other improvement activities at the site.

Source:AHN Topics:Economy, Business And Finance, Company Information, Product Recalls, Chemicals, Pharmaceutical

12:02 PM EST
12/28/2011
Plavix warning may not be neededPlavix, a popular blood thinner, is safe and effective for patients, including those who are "poor metabolizers" of the drug, a new study says.

Source:AHN Topics:Health, Medical Conditions, Economy, Business And Finance, Chemicals, Pharmaceutical

2:04 PM EST
12/27/2011
Painkiller 10 times stronger than Vicodin in the worksA new painkiller, Zohydro, 10 times stronger than Vicodin, is in development and has health experts alarmed about possible abuse. The pills are the first to contain the addictive ingredient hydrocodone in a pure form.

Source:AHN Topics:Health, Medicine, Western, Economy, Business And Finance, Chemicals, Pharmaceutical

6:52 AM EST
11/22/2011
Former Synthes executives sentenced for roles in illegal clinical trials Former executives of a medical device manufacturer acquired by Johnson & Johnson this year were sentenced on Monday for their roles in illegal clinical trials of a bone cement product on spine patients.

Source:AHN Topics:Crime, Law And Justice, Punishment, Economy, Business And Finance, Chemicals, Pharmaceutical, Lifestyle And Leisure, Consumer Issue

8:05 AM EST
11/16/2011
Local production means cheaper antiretroviral (ARV) drugsA Kenyan pharmaceutical company has been given the green light by the World Health Organization (WHO) to start producing antiretroviral (ARV) drugs, which could result in significant savings for the government's growing treatment program.

Source:IRIN Topics:Health, Disease, AIDS, Economy, Business And Finance, Chemicals, Pharmaceutical

 
Advertisement  
Advertisement
 
[ CLOSE ]
[ CLOSE ]

[ CLOSE ]

[ CLOSE ]

© 2011 AHN All Rights Reserved   |   Hosted on the NewsBahn™